• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向表皮生长因子受体的小干扰RNA可有效预防白内障手术后的后囊膜混浊。

SiRNA targeting EGFR effectively prevents posterior capsular opacification after cataract surgery.

作者信息

Huang Wan-Rong, Fan Xing-Xing, Tang Xin

机构信息

Tianjin Eye Hospital, Tianjin Medical University, Tianjin, China.

出版信息

Mol Vis. 2011;17:2349-55. Epub 2011 Aug 31.

PMID:21921987
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3171494/
Abstract

PURPOSE

We investigated the effect of epidermal growth factor receptor (EGFR) siRNA on human lens epithelium (HLE) cells and the development of posterior capsular opacity (PCO).

METHODS

We designed EGFR siRNA and used it to knockdown the expression of EGFR in HLE cells. Cell proliferation was examined by 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), cell growth curve assay and cell cycle analysis. Next, we selected an adaptable concentration of recombinant epidermal growth factor (EGF) for stimulating the growth of HLE cells to further test the suppressive effect of siRNA. At last, we established the model of PCO in rats to further investigate whether knocking down EGFR would prevent the progression of PCO in vivo.

RESULTS

The cell proliferation of EGFR siRNA group was apparently inhibited no matter in short or long term and cell cycle was arrested in G(1) phase. Over expression EGF cannot rescue the inhibition of EGFR siRNA on HLE cells and the proliferation activity in HLE cells greatly decreased when EGF-EGFR signal pathway blockaded. In vivo experiments, the extent of PCO of EGFR siRNA group is much lower than the control group.

CONCLUSIONS

Our results demonstrate that EGFR siRNA can effectively inhibit the progression of PCO. Thus, siRNA targeting EGFR may provide a totally new way for preventing PCO or even cataract.

摘要

目的

我们研究了表皮生长因子受体(EGFR)小干扰RNA(siRNA)对人晶状体上皮(HLE)细胞及后囊膜混浊(PCO)发展的影响。

方法

我们设计了EGFR siRNA,并用于敲低HLE细胞中EGFR的表达。通过3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四氮唑溴盐(MTT)、细胞生长曲线分析和细胞周期分析来检测细胞增殖。接下来,我们选择合适浓度的重组表皮生长因子(EGF)来刺激HLE细胞生长,以进一步测试siRNA的抑制作用。最后,我们建立大鼠PCO模型,以进一步研究敲低EGFR是否能在体内阻止PCO的进展。

结果

无论短期还是长期,EGFR siRNA组的细胞增殖均明显受到抑制,细胞周期停滞于G(1)期。EGF过表达不能挽救EGFR siRNA对HLE细胞的抑制作用,当EGF-EGFR信号通路被阻断时,HLE细胞的增殖活性大大降低。在体内实验中,EGFR siRNA组的PCO程度远低于对照组。

结论

我们的结果表明,EGFR siRNA可有效抑制PCO的进展。因此,靶向EGFR的siRNA可能为预防PCO甚至白内障提供一种全新的方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2309/3171494/a04a8e9f10f5/mv-v17-2349-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2309/3171494/0418528d8144/mv-v17-2349-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2309/3171494/e9912c01ced7/mv-v17-2349-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2309/3171494/f0d6cf64edc4/mv-v17-2349-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2309/3171494/2fe95e483372/mv-v17-2349-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2309/3171494/a133e68ae0dd/mv-v17-2349-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2309/3171494/f3468f75223a/mv-v17-2349-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2309/3171494/a04a8e9f10f5/mv-v17-2349-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2309/3171494/0418528d8144/mv-v17-2349-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2309/3171494/e9912c01ced7/mv-v17-2349-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2309/3171494/f0d6cf64edc4/mv-v17-2349-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2309/3171494/2fe95e483372/mv-v17-2349-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2309/3171494/a133e68ae0dd/mv-v17-2349-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2309/3171494/f3468f75223a/mv-v17-2349-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2309/3171494/a04a8e9f10f5/mv-v17-2349-f7.jpg

相似文献

1
SiRNA targeting EGFR effectively prevents posterior capsular opacification after cataract surgery.靶向表皮生长因子受体的小干扰RNA可有效预防白内障手术后的后囊膜混浊。
Mol Vis. 2011;17:2349-55. Epub 2011 Aug 31.
2
HSP90 as a novel therapeutic target for posterior capsule opacification.热休克蛋白 90 作为后发性白内障的新型治疗靶点。
Exp Eye Res. 2019 Dec;189:107821. doi: 10.1016/j.exer.2019.107821. Epub 2019 Oct 4.
3
Implication of Smad2 and Smad3 in transforming growth factor-β-induced posterior capsular opacification of human lens epithelial cells.Smad2和Smad3在转化生长因子-β诱导的人晶状体上皮细胞后囊膜混浊中的作用
Curr Eye Res. 2015 Apr;40(4):386-97. doi: 10.3109/02713683.2014.925932. Epub 2014 Jun 9.
4
SiRNA Targeting mTOR Effectively Prevents the Proliferation and Migration of Human Lens Epithelial Cells.靶向mTOR的小干扰RNA有效抑制人晶状体上皮细胞的增殖和迁移。
PLoS One. 2016 Dec 2;11(12):e0167349. doi: 10.1371/journal.pone.0167349. eCollection 2016.
5
EGFR inhibitor Gefitinib attenuates posterior capsule opacification in vitro and in the ex vivo human capsular bag model.表皮生长因子受体(EGFR)抑制剂吉非替尼在体外和离体人晶状体囊袋模型中可减轻后囊膜混浊。
Graefes Arch Clin Exp Ophthalmol. 2015 Mar;253(3):409-17. doi: 10.1007/s00417-014-2875-0. Epub 2014 Dec 5.
6
MicroRNA-34a inhibits epithelial-mesenchymal transition of lens epithelial cells by targeting Notch1.微小 RNA-34a 通过靶向 Notch1 抑制晶状体上皮细胞的上皮-间充质转化。
Exp Eye Res. 2019 Aug;185:107684. doi: 10.1016/j.exer.2019.05.024. Epub 2019 May 31.
7
Zebularine suppresses TGF-beta-induced lens epithelial cell-myofibroblast transdifferentiation by inhibiting MeCP2.泽布勒林通过抑制MeCP2来抑制转化生长因子-β诱导的晶状体上皮细胞-肌成纤维细胞转分化。
Mol Vis. 2011;17:2717-23. Epub 2011 Oct 19.
8
Effects of Interleukin-6 on posterior capsular opacification.白细胞介素-6 对后囊膜混浊的影响。
Exp Eye Res. 2018 Jul;172:94-103. doi: 10.1016/j.exer.2018.03.013. Epub 2018 Apr 1.
9
Suppression of human lens epithelial cell proliferation by proteasome inhibition, a potential defense against posterior capsular opacification.蛋白酶体抑制对人晶状体上皮细胞增殖的抑制作用:一种预防后囊膜混浊的潜在防御机制
Invest Ophthalmol Vis Sci. 2006 Oct;47(10):4482-9. doi: 10.1167/iovs.06-0139.
10
EGF receptor inhibitor erlotinib as a potential pharmacological prophylaxis for posterior capsule opacification.表皮生长因子受体抑制剂厄洛替尼作为后囊膜混浊的潜在药物预防。
Graefes Arch Clin Exp Ophthalmol. 2013 Jun;251(6):1529-40. doi: 10.1007/s00417-013-2257-z. Epub 2013 Jan 18.

引用本文的文献

1
Elevated Inflammatory Cytokines Persist in the Aqueous Humor Years After Cataract Surgery.白内障手术后数年,房水中炎症细胞因子水平持续升高。
Invest Ophthalmol Vis Sci. 2025 Apr 1;66(4):12. doi: 10.1167/iovs.66.4.12.
2
Oxidative Stress and Cataract Formation: Evaluating the Efficacy of Antioxidant Therapies.氧化应激与白内障形成:评估抗氧化疗法的疗效。
Biomolecules. 2024 Aug 25;14(9):1055. doi: 10.3390/biom14091055.
3
TGFβ overcomes FGF-induced transinhibition of EGFR in lens cells to enable fibrotic secondary cataract.TGFβ 克服 FGF 诱导的晶状体细胞中 EGFR 的反抑制作用,从而导致纤维性继发性白内障。

本文引用的文献

1
Targeting EGFR and VEGF(R) pathway cross-talk in tumor survival and angiogenesis.针对肿瘤存活和血管生成中 EGFR 和 VEGF(R) 通路的相互作用。
Pharmacol Ther. 2011 Jul;131(1):80-90. doi: 10.1016/j.pharmthera.2011.03.012. Epub 2011 Mar 23.
2
Upregulated stromal EGFR and vascular remodeling in mouse xenograft models of angiogenesis inhibitor-resistant human lung adenocarcinoma.血管生成抑制剂耐药的人肺腺癌在鼠异种移植模型中上调的基质 EGFR 和血管重塑。
J Clin Invest. 2011 Apr;121(4):1313-28. doi: 10.1172/JCI42405. Epub 2011 Mar 23.
3
Comparative effects of TGF-β2/Smad2 and TGF-β2/Smad3 signaling pathways on proliferation, migration, and extracellular matrix production in a human lens cell line.
Mol Biol Cell. 2024 Jun 1;35(6):ar75. doi: 10.1091/mbc.E24-01-0040. Epub 2024 Apr 10.
4
Tonic ErbB signaling underlies TGFβ-induced activation of ERK and is required for lens cell epithelial to myofibroblast transition.TGFβ 诱导的 ERK 激活是基于 tonic ErbB 信号的,并且对于晶状体细胞上皮到肌成纤维细胞的转变是必需的。
Mol Biol Cell. 2024 Mar 1;35(3):ar35. doi: 10.1091/mbc.E23-07-0294. Epub 2024 Jan 3.
5
Identification of Small Molecules for Prevention of Lens Epithelium-Derived Cataract Using Zebrafish.利用斑马鱼鉴定预防晶状体上皮细胞白内障的小分子。
Cells. 2023 Oct 29;12(21):2540. doi: 10.3390/cells12212540.
6
ErbBs in Lens Cell Fibrosis and Secondary Cataract.ErbB 受体在晶状体细胞纤维化和继发性白内障中的作用
Invest Ophthalmol Vis Sci. 2023 Jul 3;64(10):6. doi: 10.1167/iovs.64.10.6.
7
Roles of growth factors in eye development and ophthalmic diseases.生长因子在眼睛发育和眼科疾病中的作用。
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2022 Nov 25;51(5):613-625. doi: 10.3724/zdxbyxb-2022-0603.
8
EGF-Mediated Overexpression of Myc Attenuates miR-26b by Recruiting HDAC3 to Induce Epithelial-Mesenchymal Transition of Lens Epithelial Cells.EGF 介导的 Myc 过表达通过招募 HDAC3 来抑制 miR-26b,从而诱导晶状体上皮细胞的上皮-间质转化。
Biomed Res Int. 2018 May 30;2018:7148023. doi: 10.1155/2018/7148023. eCollection 2018.
9
MicroRNA-486-5p suppresses TGF-β2-induced proliferation, invasion and epithelial-mesenchymal transition of lens epithelial cells by targeting Smad2.微小RNA-486-5p通过靶向Smad2抑制转化生长因子-β2诱导的晶状体上皮细胞增殖、侵袭及上皮-间质转化。
J Biosci. 2017 Dec;42(4):575-584. doi: 10.1007/s12038-017-9709-2.
10
Epigenetic regulation of glycosylation and the impact on chemo-resistance in breast and ovarian cancer.糖基化的表观遗传调控及其对乳腺癌和卵巢癌化疗耐药性的影响。
Epigenetics. 2016 Dec;11(12):845-857. doi: 10.1080/15592294.2016.1241932. Epub 2016 Sep 30.
TGF-β2/Smad2 和 TGF-β2/Smad3 信号通路对人晶状体细胞系增殖、迁移和细胞外基质产生的比较影响。
Exp Eye Res. 2011 Mar;92(3):173-9. doi: 10.1016/j.exer.2011.01.009. Epub 2011 Jan 27.
4
Interventions for preventing posterior capsule opacification.预防后囊膜混浊的干预措施。
Cochrane Database Syst Rev. 2010 Feb 17;2010(2):CD003738. doi: 10.1002/14651858.CD003738.pub3.
5
Growth factor receptor expression in anal squamous lesions: modifications associated with oncogenic human papillomavirus and human immunodeficiency virus.肛门鳞状病变中生长因子受体的表达:与致癌性人乳头瘤病毒和人类免疫缺陷病毒相关的改变
Hum Pathol. 2009 Nov;40(11):1517-27. doi: 10.1016/j.humpath.2009.05.010. Epub 2009 Aug 27.
6
Posterior capsular opacification: a problem reduced but not yet eradicated.后囊膜混浊:问题有所减轻但尚未根除。
Arch Ophthalmol. 2009 Apr;127(4):555-62. doi: 10.1001/archophthalmol.2009.3.
7
Disruption of growth hormone receptor prevents calorie restriction from improving insulin action and longevity.生长激素受体的破坏会阻止热量限制改善胰岛素作用和延长寿命。
PLoS One. 2009;4(2):e4567. doi: 10.1371/journal.pone.0004567. Epub 2009 Feb 23.
8
Posterior capsule opacification.后囊膜混浊。
Exp Eye Res. 2009 Feb;88(2):257-69. doi: 10.1016/j.exer.2008.10.016. Epub 2008 Oct 29.
9
ErbB receptors: from oncogenes to targeted cancer therapies.表皮生长因子受体:从癌基因到癌症靶向治疗
J Clin Invest. 2007 Aug;117(8):2051-8. doi: 10.1172/JCI32278.
10
Suppression of ocular neovascularization with siRNA targeting VEGF receptor 1.用靶向血管内皮生长因子受体1的小干扰RNA抑制眼部新生血管形成
Gene Ther. 2006 Feb;13(3):225-34. doi: 10.1038/sj.gt.3302641.